1Degertekin M, Serruys PW, Foley DP, et al. Persistent iinhibifion of neointimal hyperplasia after sirolimus-eluting stents implantation :long-term ( up to 2 years ) clinical, angiographic and intravascular ultrasound follow-up. Circulation, 2001,106 : 1610-1-613.
2Mcfadden EP,Stabile E,Regar E, et al. Late thrombosis in drugeluting coronary stents after discontinuation of antiplatelet therapy. Lancet ,2004,364 : 1519-1521.
3Reimers S, Moussa I, Akiyama T, et al. Long-term follow-up after successful repeat percutaneous intervention for stent restenosis. J Am Coil Cardiol, 1997,30 : 186-192.
4Mehta SR,Cannon CP, Fox KA, et sl. Routing vs selective invasive strategies in patients with acute coronary syndromes:a collaborative meta-analysis of randomizes trials. JAMA, 2005,293 : 2908-2917.
5Bauter C, Hubert E, Prat A, et al. Predictors of restenosis after coronary stems implantation. J Am CollCardiol, 1998,31:1291- 1298.
6Berenguer A, Mainar V, Border P, et al. Incidence and predictors of restenosis after sirolimus-eluting stent implantation in high-risk patients. Am Heart J, 2005,150:536-542.
7Holmes DR,Lein MB,Moses JW,et al. Analysis of 1-year clinical outcome in the SIRIUS trial: a randomized trial of a sirolimus-sluting stents versus a standard stents in patients at high risk for coronary restenosis. Circulation, 2004,109 : 634-640.
8Moussa I, Leon MB, Baim DS, et al. Impact of sirolimus-eluting stents on outcome in patients in diabetic patients: a SIRIUS (Sirolimus-Coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary lesions) substudy. Circulation, 2004,109:2273-2278.
9Degertekin M, Regar E, Tanabe K, et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis ;the first clinical experience. J Am Coil Cardiol,2003,41:184-189.
